Greykasell Wealth Strategies, Inc.
Position in CRSP — CRISPR Therapeutics AG
CIK 2041220
DANVILLE, CA
Position in CRSP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,708
+$474 QoQ
Shares Held
68
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#438
of 519 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Greykasell Wealth Strategies, Inc. holds $320,635 across 3 Biotechnology names. CRSP ranks #3 (1.2% of the industry book) .
All Filings in CRSP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,708 | 68 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,234 | 68 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,565 | 68 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,407 | 68 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,307 | 68 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,314 | 68 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||